PML and glioma: In contrast, overexpression of PML in H3.3 K27M glioma cells reduced overall cell viability by 30% relative to untreated controls; however, treatment with ATO had no further effects on cell viability, and CMV-PML cells were resistant to ATO compared to WT PML counterparts (Additional file 1: Fig. S6H).